Resource Type: Brochures

Our experience conducting Phase I/II adaptive oncology clinical trials, through to Phase III rescue studies spans almost 3 decades. This has given us a deep understanding of managing these complex hospital-based studies.Our goal is the same as yours: to improve patients’ lives. Patient recruitment and retention are key, and at the heart of this is…

With almost 30 years of experience, Simbec-Orion provides the expertise your clinical development programme needs, with a flexible, quality focussed approach. Our global reach ensures our ability to identify the patient populations and Key Opinion Leaders required to move your trial from concept to completion.

The team based at our MHRA-accredited facility has significant experience in First-in-Human trials with a strong focus on participant safety, risk management, and adding maximum value to your protocol through adaptive trial design.Using our knowledge and expertise, we advise on enhancements to your protocol development and study design approach, ensuring quality is built in from…

Our multi-disciplinary team of experienced laboratory scientists and project managers deliver a tailor-made Central Laboratory Service solution for both biotech and pharma companies, as well as other CROs. As an integrated element of Simbec-Orion,our on-site location provides rapid clinical trial testing for our Clinical Pharmacology studies, in addition to acting as the central laboratory for…

We’ve encountered many unique challenges that hinder complex hospital- based studies, including rare diseases and oncology trials. As a full-service, global, CRO of our size, we’re ideally placed to meet a diverse range of challenges head-on.From maximising site selection to forming close links with patient advocacy groups, and enrolling patients, we overcome hurdles to help…

Simbec-Orion is a responsive, agile full-service and tech enabled global CRO, with wide therapeutic experience and specialist expertise in clinical pharmacology, oncology and rare diseases. Perfectly structured, we provide full-service clinical development solutions for small and mid-size drug developers  – headed up by a centralised leadership team